Form 4: Coherus BioSciences Director, Lee Nisley Newcomer, Acquires Stock Options
SEC Form 4
Director Lee Nisley Newcomer acquired stock options for 112,000 shares of Coherus BioSciences on June 3, 2024.
Summary
- On June 3, 2024, Lee Nisley Newcomer, a director of Coherus BioSciences, acquired stock options for 112,000 shares.
- The exercise price of these options is $1.76.
- The options vest 100% on June 3, 2025, contingent upon continued service with the company.
- The options expire on June 3, 2034.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The acquisition of options could be seen as a slightly positive sign, but it's not definitive.
Positives
- The acquisition of stock options by a director may signal confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company director.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of the stock option acquisition. |
| 06/03/2025 | Date the stock options fully vest. |
| 06/03/2034 | Expiration date of the stock options. |
| 06/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.